Artificial intelligence for diagnosing eye diseases with eye scans
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether a computer program (artificial intelligence) can use your eye scan images to help diagnose certain eye conditions. It might help catch problems earlier or more accurately, which could lead to better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are of any age or sex.
- You have had an OCT or OCTA eye scan (a special scan of the back of the eye) as part of your regular care at Peking Union Medical College Hospital.
- You have been diagnosed with at least one of these: diabetic retinopathy, branch or central retinal vein occlusion, age-related macular degeneration, pathologic myopia with choroidal neovascularization, or glaucoma with optic nerve damage.
- Your eye scan images are clear enough for analysis (not blurry or incomplete).
- You can give consent, or your medical records are available for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to help diagnose eye conditions from digital eye images. If you have certain types of eye images from regular check-ups, your data might help teach the AI to recognise diseases better.
This study tests an intelligent system that uses your eye scans to help diagnose multiple eye conditions. If you have a clear eye scan and one of the listed conditions, this trial might help improve diagnosis and monitoring.
This trial tests an AI system that automatically checks eye photos for signs of diabetic retinopathy, a diabetes complication that can harm vision. If you have diabetes, this study may help detect the condition earlier and prevent vision loss.
This study tests whether an AI system can help eye doctors write clearer and more accurate reports on retinal images (photos of the back of the eye). The focus is on how doctors and AI work together to describe eye findings.
This study uses an AI program called DRISTi to screen for diabetic eye disease by taking pictures of the back of your eye. It's designed for adults with diabetes who haven't had major eye treatments or vision loss.
This study tests an artificial intelligence (AI) system that looks at eye images to find early signs of glaucoma, a condition that can damage the optic nerve and lead to vision loss. The goal is to see if the AI can accurately tell apart people with glaucoma from those with healthy eyes, which could help with earlier diagnosis and treatment.
Hear when a new Pathologic Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.